In a statement, Abeona CEO Vish Seshadri expressed surprise and disappointment in the decision and said the company anticipates completing a BLA resubmission in the third quarter of 2024 with necessary updates to fully satisfy all the deficiencies outlined in the CRL. Pz-cel was highlighted this week in BioSpace s 5 Cell and Gene Therapy Decisions to Watch in 2024
These liposomes strongly bound to A, inhibited its aggregation by 70%, and disaggregated preformed aggregates by 60%
Atrocious Alias: Given that he lives in an underwater society where the word "barnacle" is sometimes used as an expletive, it's likely a factor as to why he's treated with less respect than Mermaid Man
Advanced testing for immune reactions to wheat, gluten, and intestinal permeability
Taking the forward direction of step 6 as an example, the covalent adduct formed between thiamine pyrophosphate and xylulose 5-phosphate undergoes cleavage at the C-2C-3 bond
He probably could be a real threat to reckon with, but for all the reasons listed above, he would fail at being a credible villain too
